Company Quick10K Filing
HST Global
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-04-09
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-20
10-Q 2019-03-31 Filed 2019-05-16
10-K 2018-12-31 Filed 2019-04-02
10-Q 2018-09-30 Filed 2018-11-02
10-Q 2018-06-30 Filed 2018-08-13
10-Q 2018-03-31 Filed 2018-05-07
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-16
10-Q 2016-03-31 Filed 2016-05-17
10-K 2015-12-31 Filed 2016-04-13
10-Q 2015-09-30 Filed 2015-10-26
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-20
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2013-12-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-04-04
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-15
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-16
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-17
10-K 2011-12-31 Filed 2012-04-13
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-17
10-K 2010-12-31 Filed 2011-05-13
10-Q 2010-09-30 Filed 2010-11-19
10-Q 2010-06-30 Filed 2010-08-20
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-04-15
8-K 2020-04-28
8-K 2019-08-22

HSTC 10Q Quarterly Report

Part I - Financial Information
Item 1. Financial Statements
Note 1 - Organization and Principal Activities
Note 2 - Significant Accounting Policies
Note 3 - Going Concern
Note 4 - Related Party Transactions
Note 5 - Common Stock
Note 6 - Subsequent Events
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures.
Part Ii: Other Information
Item 1. Legal Proceedings
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
EX-31 exhibit31-1.htm
EX-31 exhibit31-2.htm
EX-32 exhibit32-1.htm
EX-32 exhibit32-2.htm

HST Global Earnings 2020-03-31

Balance SheetIncome StatementCash Flow
0.1-0.6-1.3-2.1-2.8-3.52012201420172020
Assets, Equity
0.60.50.30.20.0-0.12016201720182020
Rev, G Profit, Net Income
0.10.10.0-0.0-0.1-0.12012201420172020
Ops, Inv, Fin

HST Global, Inc. - Form 10-Q SEC filing
0000797564 --12-31 Non-accelerated Filer Yes Yes false true false false 2020 Q1 true false 0000797564 2020-01-01 2020-03-31 0000797564 2020-03-31 0000797564 2019-12-31 0000797564 2019-01-01 2019-03-31 0000797564 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000797564 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000797564 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000797564 us-gaap:ParentMember 2020-01-01 2020-03-31 0000797564 2018-12-31 0000797564 us-gaap:CommonStockMember 2018-12-31 0000797564 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000797564 us-gaap:RetainedEarningsMember 2018-12-31 0000797564 us-gaap:ParentMember 2018-12-31 0000797564 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000797564 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000797564 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000797564 us-gaap:ParentMember 2019-01-01 2019-03-31 0000797564 2019-03-31 0000797564 us-gaap:CommonStockMember 2019-03-31 0000797564 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000797564 us-gaap:RetainedEarningsMember 2019-03-31 0000797564 us-gaap:ParentMember 2019-03-31 0000797564 us-gaap:CommonStockMember 2019-12-31 0000797564 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000797564 us-gaap:RetainedEarningsMember 2019-12-31 0000797564 us-gaap:ParentMember 2019-12-31 0000797564 us-gaap:CommonStockMember 2020-03-31 0000797564 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000797564 us-gaap:RetainedEarningsMember 2020-03-31 0000797564 us-gaap:ParentMember 2020-03-31 0000797564 fil:NotesPayableRelatedPartiesMember 2020-01-01 2020-03-31 0000797564 fil:ExecutiveOfficesMember 2020-01-01 2020-03-31 0000797564 fil:HowellConsultingAgreementMember 2020-01-01 2020-03-31 0000797564 fil:HowellConsultingAgreementMember 2019-12-31 0000797564 fil:HowellConsultingAgreementMember 2020-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[x]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended

March 31, 2020

or

[  ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

For the transition period from

 

to

 

 

Commission file number 000-15303

 

HST Global, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

73-1215433

(State or other jurisdiction of incorporation or organization)

(I. R. S. Employer Identification No.)

 

 

150 Research Drive, Hampton, VA

23666

(Address of principal executive offices)

(Zip Code)

 

757-766-6100

(Registrant’s telephone number, including area code)

 

n/a

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

 

None

 

 

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 

Yes [x]  No [  ]


Page 1


Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x]  No [  ] 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  [  ]

Accelerated filer  [  ]

Non-accelerated filer  [ x ]

Smaller reporting company  [x]

Emerging growth Company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [  ] 

 

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act).  Yes [  ]  No [x] 

 

The number of shares of the registrant’s common stock outstanding as of March 31, 2020 was 4,247,993 shares.


Page 2


TABLE OF CONTENTS

PART I

FINANCIAL INFORMATION

3

Item 1. 

Financial Statements

4

 

Condensed Balance Sheets (unaudited)

4

 

Condensed Statements of Operations (unaudited)

5

 

Condensed Statements of Shareholder Equity (Deficit) (unaudited)

6

 

Condensed Statements of Cash Flow (unaudited)

7

 

Notes to Condensed Financial Statements (unaudited)

8

Item 2.

Management’s Discussion and Analysis of Financial Conditions and Results of Operations

16

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

17

Item 4.

Controls and Procedures

18

PART II

OTHER INFORMATION

19

Item 1.

Legal Proceedings

19

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

19

Item 3.

Default Upon Senior Securities

19

Item 4.

Mine Safety Disclosures

19

Item 5.

Other Information

19

Item 6.

Exhibits

19

Signatures

 

20


Page 3


PART I – FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

 

HST GLOBAL, INC.

Condensed Balance Sheets

 

March 31, 2020

 

December 31,
2019

 

(Unaudited)  

 

 

ASSETS

 

 

 

 

 

 

 

Current Assets

 

 

 

Cash and cash equivalents

- 

 

$1,955  

Prepaid Expenses

- 

 

-  

Total Current Assets

- 

 

1,955  

Total Assets

$- 

 

$1,955  

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

Current Liabilities

 

 

 

Bank overdraft payable

$2,113  

 

$-  

Accounts payable and accrued expenses

1,571  

 

3,910  

Accounts payable and accrued expenses - related parties

1,490  

 

1,475  

Accrued officer compensation

30,000  

 

-  

Notes payable - related party

3,090  

 

-  

Total Current Liabilities

38,264  

 

5,385  

Total Liabilities

38,264  

 

5,385  

 

 

 

 

Stockholders' Deficit

 

 

 

Preferred stock; 10,000,000 shares authorized,
respectively, at $0.001 par value, - 0- shares issued and
outstanding at March 31, 2020 and December 31, 2019
respectively  

-  

 

-  

Common stock; 200,000,000 shares
authorized, respectively, at $0.001 par value, 4,247,993
and 4,247,993 shares issued and outstanding at March
31, 2020 and December 31, 2019, respectively

4,248  

 

4,248  

Additional paid-in capital

5,358,236  

 

5,358,236  

Accumulated deficit

(5,400,748) 

 

(5,365,914) 

Total Stockholders' Deficit

(38,264) 

 

(3,430) 

Total Liabilities and Stockholders' Deficit

$-  

 

$1,955  

 

 


The accompanying notes are an integral part of these unaudited condensed financial statements

Page 4


 

HST GLOBAL, INC.

Condensed Statements of Operations

(Unaudited)

 

For the Three Months

Ended March 31, 2020

For the Three Months

Ended March 31, 2019

REVENUES

$-  

 

$-  

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

Consulting

30,000  

 

30,000  

 

General and administrative

4,818  

 

6,308  

 

 

 

 

 

 

Total Operating Expenses

34,818  

 

36,308  

 

 

 

 

 

 

Loss from Operations

(34,818) 

 

(36,308) 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

Interest expense

(15) 

 

(8,937) 

 

 

 

 

 

 

Total Other Income (Expense)

(15) 

 

(8,937) 

 

 

 

 

 

 

Loss Before Income Taxes

(34,833 

 

(45,245) 

 

Provision for Income Taxes

-  

 

-  

 

NET LOSS

$(34,833) 

 

$(45,245) 

 

 

 

 

 

 

Basic and Diluted Loss Per Share

$(0.01) 

 

$(0.00) 

 

 

 

 

 

 

Basic and Diluted Weighted Average
Number of Common Shares Outstanding

3,268,814  

 

2,447,991  

 


The accompanying notes are an integral part of these unaudited condensed financial statements

Page 5


HST Global, Inc.

Condensed Statements of Stockholders’ Deficit
(Unaudited)

Preferred Stock

Common Stock

Additional Paid-in

Accumulated

Total Stockholder’s

 

Shares

Amount

Shares

Amount

Capital

Deficit

Deficit

 

 

 

 

 

 

 

 

Balance, December 31, 2018

- 

$- 

2,447,991 

$2,448 

$2,419,096 

$(5,792,486) 

$(3,370,942) 

Net loss

- 

- 

- 

- 

- 

(45,245) 

(45,245) 

Balance, March 31, 2019

- 

$- 

2,447,991 

$2,448 

$2,419,096 

$(5,837,731) 

$(3,416,187) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2019

- 

$- 

4,247,993 

$4,248 

5,358,236 

$(5,365,914) 

$(3,430) 

Net loss

- 

- 

-

- 

- 

(34,833 

(34,833) 

Balance, March 31, 2020

- 

$- 

4,247,993

$4,248 

$5,358,236 

$(5400747) 

$(38263) 


The accompanying notes are an integral part of these unaudited condensed financial statements

Page 6


HST GLOBAL, INC.

Condensed Statements of Cash Flows

(Unaudited)

 

For the Three Months Ended

March 31,20 20

 

For the Three Months Ended

March 31, 2019

Operating Activities

 

 

 

Net loss

$(34,833 

 

$(45,245) 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Gain on extinguishment of debt

-  

 

-  

Changes in operating assets and liabilities:

 

 

 

Prepaid Expense

-  

 

-  

Bank overdraft payable

2,113  

 

126  

Notes payable related party

3,090  

 

-  

Accounts payable and accrued expenses

(2,340) 

 

6,182  

Accrued officer compensation

30,000  

 

30,000  

Accrued related party interest

15  

 

8,937  

Net Cash Used in Operating Activities

(1,955) 

 

- 

 

 

 

 

Investing Activities

 

 

 

Net Cash Used in Investing Activities

-  

 

-  

 

 

 

 

Financing Activities

 

 

 

Proceeds from sale of common stock

-  

 

-  

Proceeds from notes payable - related party

-  

 

-  

Net Cash Provided by Financing Activities

-  

 

-  

 

 

 

 

Net Change in Cash and Cash Equivalents

(1,955 

 

-  

 

 

 

 

Cash and Cash Equivalents at Beginning of Period

1,955  

 

-  

 

 

 

 

Cash and Cash Equivalents at End of Period

$-  

 

$-  

 

 

 

 

Supplemental Disclosures of Cash Flow Information:

 

 

 

Cash paid for interest

$-  

 

$-  

Cash paid for taxes

$-  

 

$-  


The accompanying notes are an integral part of these unaudited condensed financial statements

Page 7


HST GLOBAL, INC.

Notes to Condensed Financial Statements (Unaudited)

September 30, 2019

NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES

HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations.  Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.

The accompanying interim financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnotes necessary for a complete presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. The unaudited quarterly financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K of the Company as of and for the fiscal year ended December 31, 2019. The results of operations for the period ended March 31, 2020, are not necessarily indicative of the results for a full-year period.

HST Global, Inc. is an integrated Health and Wellness Biotechnology company that intends to developing and/or acquiring a network of Wellness Centers worldwide with the primary focus on homeopathic and alternative treatments of late stage cancer and other life threatening diseases.  In addition, the Company intends to acquire innovative products for the treatment of life threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer and/or life threatening diseases.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K and 10-Q.  

Accounting Method

The Company’s financial statements are prepared using the accrual method of accounting.  The Company has elected a December 31 year-end.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and


Page 8


liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

Basic and Diluted Income (Loss) Per Share

The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

Stock-Based Compensation

The Company adopted ASC 718, “Stock Compensation”, upon inception at August 6, 2007. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the income statement based on their fair values. As of  March 31, 2020, the Company has not issued any employer stock options.

Fair Value of Financial Instruments

The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.

The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis.

Recently Issued Accounting Pronouncements

Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

NOTE 3 – GOING CONCERN

The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern for a period of one year from the issuance of these financial statements. The ability of the Company to continue as a going concern is dependent on the Company


Page 9


obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.  These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.

Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the money it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

NOTE 4 – RELATED PARTY TRANSACTIONS

Notes Payable – Related Parties

During the quarter ended March 31, 2020, the Company received $3,090 in additional cash loans from Ronald R. Howell.

Executive Offices

The Company’s executive offices are located at 150 Research Dr., Hampton VA.  These offices are leased by The Health Network, Inc. (“HTN”), of which Ron Howell is President.  THN allows the Company to use the office space without a formal sublease or rental agreement.

Consulting Agreements

The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010.  The Company had agreed to continue to engage Mr. Howell as a consultant until his consulting services are no longer required. The agreement was suspended from July, 2019 through December, 2019 due to the pendency of the Asset Purchase Agreement with Orbital Group, Inc. (the “APA”), and has resumed beginning in January, 2020 due to the termination of the APA.  As of December 31, 2019, the Company owed Mr. Howell $0 under the consulting agreement.  As of March 31, 2020, the Company owed Mr. Howell $30,000 under the consulting agreement.

NOTE 5 – COMMON STOCK

None

 

NOTE 6 – SUBSEQUENT EVENTS

In accordance with ASC 855, Company management reviewed all material events through the date of this report and determined that there are no other material subsequent events to report.

 


Page 10


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the information contained in the condensed financial statements of the Company and the notes thereto appearing elsewhere herein.  As used in this report, the terms "Company", "we", "our", "us" and "HSTC" refer to HST Global, Inc.

Preliminary Note Regarding Forward-Looking Statements

This quarterly report contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as "anticipate," "expect," "intend," "plan," "will," "we believe," "HSTC believes," "management believes" and similar language. The forward-looking statements are based on the current expectations of HSTC and are subject to certain risks, uncertainties and assumptions, including those set forth in the discussion under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this report. The actual results may differ materially from results anticipated in these forward-looking statements. We base the forward-looking statements on information currently available to us, and we assume no obligation to update them.  Investors are also advised to refer to the information in our filings with the Securities and Exchange Commission, especially on Forms 10-K, 10-Q and 8-K, in which we discuss in more detail various important factors that could cause actual results to differ from expected or historic results. It is not possible to foresee or identify all such factors. As such, investors should not consider any list of such factors to be an exhaustive statement of all risks and uncertainties or potentially inaccurate assumptions.

Critical Accounting Policies and Estimates

Our financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States ("US GAAP"). US GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenues and expense amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.

Results of Operations – The Three Months Ended March 31, 2020as Compared to the Three Months Ended March 31, 2019

The Company had no revenues or costs of sales during 2020 or 2019. The Company realized net loss of $34,833 for the quarter ended March 31, 2020 as compared to a net loss of $45,245 for the quarter ended March 31, 2019. The decrease in net loss of $10,412 for the 1st quarter of 2020 is attributable to a decrease of accounts payable. Operating expense were $55,008 for the period ended September 30, 2019 as compared to $34,638 at September 30, 2018.

Results of Operations – The Three Months Ended March 31, 2020 as Compared to the Three Months Ended March 31, 2019

The Company had no revenues or costs of sales for the three month periods of 2020 or 2019. The Company incurred net loss of $34,833 for the three months ended March 31, 2020 as compared to a net loss of $45,245 for the three months ended March 31, 2019.  The operating expenses in the first quarters of 2020 were $34,833 versus $45,245 for the same period in 2019.  The decrease was based on the decrease of accounts payable.


Page 11


Liquidity and Capital Resources

Operating Activities.  

Our cash balance as of March 31, 2020 was an overdraft balance of $2,113, with an overdraft balance of $126 on March 31, 2019.

Financing Activities.

The Company has paid for its operations through proceeds of $80,000 in the period of July 1, 2019 to September 30, 2019  from the private placement to unrelated third parties related parties, in addition to $3,090 received from related party notes payable. In the three months ended March 31, 2020 the company received advances in the form of loans from related parties in an amount of $3,090.

The Company does not currently have sufficient capital in its accounts, nor sufficient firm commitments for capital to assure its ability to meet its current obligations or to continue its planned operations. The Company is continuing to pursue working capital and additional revenue through the seeking of the capital it needs to carry on its planned operations. There is no assurance that any of the planned activities will be successful.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

None.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Interim Chief Financial Officer (the "Certifying Officer") maintains a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management timely. Under the supervision and with the participation of management, the Certifying Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule [13a-14(c)/15d-14(c)] under the Exchange Act) within 45 days prior to the filing date of this report. Based upon that evaluation, the Certifying Officer concluded that our disclosure controls and procedures are not effective in timely alerting them to material information relative to our company required to be disclosed in our periodic filings with the SEC.

Changes in Internal Controls

During the Quarter ended March 31, 2020, there were no changes made to our internal controls over financial reporting that are reasonably likely to affect the reliability of those controls, or the accuracy of our financial reporting.  


Page 12


PART II: OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

None.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

In the three months period from July 1, 2019 to September 30, 2019, the company agreed to issue 12,000,000 shares for proceeds of $80,000 in a private placement. The securities were issued to investors in reliance upon the exemption from registration requirements of the Securities Act, as set forth in Section 4(2) under the Securities Act and Regulation D promulgated thereunder relating to transactions by an issuer not involving any public offering.

The proceeds of this offering were used for general working capital purposes, which included the cost of due diligence on opportunities to expand the Company’s health care related business focus. Funds were used to pay the cost of using outside consultants to do analysis of expansion opportunities and to advise the company on operating procedures. The Company does plan on raising additional capital for working capital and for investment in new business operations.  

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.  MINE SAFETY DISCLOSURES

None.

ITEM 5.  OTHER INFORMATION

None.

ITEM 6.  EXHIBITS

The following exhibits are filed as part of this quarterly report on Form 10-Q:

Exhibit No.

 

Description

31.1

 

Certification by the Chief Executive Officer of Competitive Technologies, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).

31.2

 

Certification by the Chief Financial Officer of Competitive Technologies, Inc. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a)).

32.1

 

Certification by the Chief Executive Officer of Competitive Technologies, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

32.2

 

Certification by the Chief Financial Officer of Competitive Technologies, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

101

 

Interactive Data Files


Page 13


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: May 15, 2020

 

HST GLOBAL, INC.

 

 

(the registrant)

 

 

 

 

 

By:

\s\ Ron Howell

 

 

Ron Howell

 

 

Chief Executive Officer

 

 

Interim Chief Financial Officer


Page 14